trial · primary record
Vedolizumab
Collagenous Gastritis
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 11 |
| Primary completion | 2026-10 |
| Primary endpoint | Change in symtpoms |
| Registry ID | NCT06317220 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:26.210Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06317220
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- VEDOLIZUMAB · approval
- Vedolizumab · compound